Lataa...
Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies
High levels of HDL cholesterol (HDL-C) have traditionally been linked to lower incidence of cardiovascular disease, prompting the search for effective and safe HDL-C raising pharmaceutical agents. Although drugs such as niacin and fibrates represent established therapeutic approaches, HDL-C response...
Tallennettuna:
| Julkaisussa: | Expert Rev Cardiovasc Ther |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5347146/ https://ncbi.nlm.nih.gov/pubmed/23469915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/erc.12.134 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|